Loading
AUTHOR INFO
Laura E. Davis
Case Western Reserve University Hospitals Urology Institute, Cleveland, OH, USAArticles List
Cytoreductive Nephrectomy Following Immunotherapy: Evolution, Pearls, and Pitfalls of Treatment
Adam Calaway , Eric A. Singer , Laura E. Davis , Shawn Dason
Renal Cell Carcinoma (RCC) is among the most frequently diagnosed malignancies in both genders with over 81,000 estimated cases in 2024. Despite increasing incidence of renal cell carcinomas <4 cm, up to 1/3 of patients diagnosed with RCC exhibit metastatic disease (mRCC) at time of diagnosis. Cytoreductive nephrectomy (CN), a procedure which encompasses the surgical removal of the primary tumor in patients with metastatic disease
J Cell Immunol, 2024, Volume 6, Issue 4, p163-170 | DOI: 10.33696/immunology.6.202
Co Authors
Adam Calaway
Case Western Reserve University Hospitals Urology Institute, Case Western Reserve University Hospitals Urology Institute, Cleveland, OH, USA
View Profile
Eric A. Singer
The Ohio State University Comprehensive Cancer Center, Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
View Profile
Shawn Dason
The Ohio State University Comprehensive Cancer Center, Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
View Profile